Results from the Hyperopia Treatment Study 1 (HTS1) have proven to be inconclusive after three years of follow-up in young children with moderate to severe hyperopia treated with glasses compared with observation.
Ophthalmologists, like many physicians in the field of medicine, are finding it increasingly challenging to maintain the pace that operating a practice in today’s business climate requires.
For ophthalmology practices, drug prices continue to be an issue for patients and step-therapy and pre-authorization are responses to increasing drug costs, which exceed any other component of health care.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
